Akeso’s Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer
Share Facebook Twitter LinkedIn Pinterest Email Check out the full Los Angeles Dodgers’ Trophy Ceremony from the 2025 World Series!
